G. Lukina

1.2k total citations
94 papers, 633 citations indexed

About

G. Lukina is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, G. Lukina has authored 94 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Rheumatology, 27 papers in Immunology and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in G. Lukina's work include Rheumatoid Arthritis Research and Therapies (67 papers), Systemic Lupus Erythematosus Research (27 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). G. Lukina is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (67 papers), Systemic Lupus Erythematosus Research (27 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). G. Lukina collaborates with scholars based in Russia, Finland and Czechia. G. Lukina's co-authors include Tore K Kvien, Cem Gabay, Karel Pavelká, Dan Nordström, Ronald van Vollenhoven, Matija Tomšič, Merete Lund Hetland, Elisabeth Lie, Katerina Chatzidionysiou and Juan J. Gómez‐Reino and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Arthritis Research & Therapy.

In The Last Decade

G. Lukina

76 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Lukina Russia	11	517	187	157	142	115	94	633
Anna Jamnitski Netherlands	8	447 0.9×	308 1.6×	147 0.9×	71 0.5×	125 1.1×	9	617
Lena Innala Sweden	7	520 1.0×	105 0.6×	77 0.5×	62 0.4×	109 0.9×	11	630
Ani John United States	14	416 0.8×	107 0.6×	166 1.1×	103 0.7×	23 0.2×	30	575
Sharzad Emamikia Sweden	11	425 0.8×	198 1.1×	84 0.5×	57 0.4×	93 0.8×	19	497
A. Friedman United States	9	621 1.2×	337 1.8×	94 0.6×	43 0.3×	102 0.9×	25	743
P. B. J. de Sonnaville Netherlands	14	525 1.0×	88 0.5×	195 1.2×	123 0.9×	51 0.4×	18	599
Liliana Morales Argentina	2	469 0.9×	134 0.7×	236 1.5×	141 1.0×	29 0.3×	2	625
D Logar Slovenia	13	336 0.6×	85 0.5×	53 0.3×	95 0.7×	46 0.4×	17	509
Spyros N. Nikas Greece	12	335 0.6×	119 0.6×	108 0.7×	39 0.3×	34 0.3×	16	506
DJ Wallace United States	13	555 1.1×	348 1.9×	62 0.4×	24 0.2×	136 1.2×	24	732

Countries citing papers authored by G. Lukina

Since Specialization

Citations

This map shows the geographic impact of G. Lukina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Lukina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Lukina more than expected).

Fields of papers citing papers by G. Lukina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Lukina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Lukina. The network helps show where G. Lukina may publish in the future.

Co-authorship network of co-authors of G. Lukina

This figure shows the co-authorship network connecting the top 25 collaborators of G. Lukina. A scholar is included among the top collaborators of G. Lukina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Lukina. G. Lukina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Костинов, М. П., et al.. (2024). Immunogenicity and Safety of 13-valent Conjugated Pneumococcal Vaccine in Patients with Rheumatoid Arthritis. SHILAP Revista de lepidopterología. 23(1). 77–88.

Новиков, А. А., et al.. (2024). Methodological aspects of anti-nuclear antibodies detection: EFLM, EASI, ICAP AND RAMLD recommendations. Medical alphabet. 21–25.

Трошина, Е. А., et al.. (2023). Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations. SHILAP Revista de lepidopterología. 61(5). 545–553.

Lukina, G., et al.. (2021). Comparative efficacy of genetically engineered biological drugs in real clinical practice according to the Moscow Unified Arthritis Registry (MUAR) data. Russian Medical Inquiry. 5(2). 58–63.

Александрова, Е Н, А. А. Новиков, G. Lukina, & А И Парфенов. (2021). Clinical value of antibodies in inflammatory bowel diseases. Terapevticheskii arkhiv. 93(2). 228–235. 2 indexed citations

Lukina, G., et al.. (2020). Survival of bDMARDs in bionaive patients with rheumatoid arthritis: data from a retrospective 12-month follow-up. SHILAP Revista de lepidopterología. 92(5). 39–45. 3 indexed citations

Александрова, Е Н, et al.. (2019). [Clinical value of multiplex immune assay of antinuclear antibodies in systemic lupus erythematosus.]. PubMed. 63(7). 434–438. 1 indexed citations

Lauper, Kim, Denis Mongin, Florenzo Iannone, et al.. (2019). Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 50(1). 17–24. 18 indexed citations

Lukina, G., et al.. (2019). ADVERSE EVENTS OF INFLIXIMAB: FROM PUBLICATION ANALYSIS TO ORIGINAL STUDIES. The Bulletin of Contemporary Clinical Medicine. 12(1). 11–18.

10.

Kalyoncu, Umut, et al.. (2018). Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice. SHILAP Revista de lepidopterología. 3 indexed citations

11.

Белов, Б. С., et al.. (2018). Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases. Meditsinskiy sovet = Medical Council. 106–110. 6 indexed citations

12.

Chen, Yi‐Hsing, Umut Kalyoncu, Lyndon Llamado, et al.. (2018). Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice. Biologics. Volume 12. 1–9. 7 indexed citations

13.

Lauper, Kim, Dan Nordström, Karel Pavelká, et al.. (2018). Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration. Annals of the Rheumatic Diseases. 77(9). 1276–1282. 49 indexed citations

14.

Lukina, G., et al.. (2018). Efficacy and tolerability of abatacept treatment: results of 12 months observation. Terapevticheskii arkhiv. 90(5). 44–49. 1 indexed citations

15.

Chatzidionysiou, Katerina, Elisabeth Lie, G. Lukina, et al.. (2017). Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration. The Journal of Rheumatology. 44(2). 162–169. 16 indexed citations

16.

Каратеев, Д. Е., et al.. (2016). Use of tofacitinib in real clinical practice to treat patients with rheumatoid arthritis resistant to synthetic and biological disease-modifying antirheumatic drugs: Results of a multicenter observational study. SHILAP Revista de lepidopterología. 3 indexed citations

17.

Лучихина, Е. Л., Д. Е. Каратеев, G. Lukina, et al.. (2016). POSSIBILITIES FOR PRESERVING THE RESULTS OF TREATMENT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER DOSE REDUCTION AND/OR DISCONTINUATION OF BIOLOGICAL AGENTS: A REMARCA STUDY. Modern Rheumatology Journal. 10(4). 16–20. 2 indexed citations

18.

Lukina, G., et al.. (2015). AB0465 Comparison of Abatacept Efficacy and Safety in Different Stages Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 74. 1051–1051.

19.

Chatzidionysiou, Katerina, Elisabeth Lie, Е. Л. Насонов, et al.. (2011). Efficacy of different doses of rituximab for the treatment of rheumatoid arthritis: Data from the CERERRA collaboration.. Research at the University of Copenhagen (University of Copenhagen). 1 indexed citations

20.

Chatzidionysiou, Katerina, Elisabeth Lie, E L Nasonov, et al.. (2011). Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration. Annals of the Rheumatic Diseases. 71(3). 374–377. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact